Convergent mechanisms for recognition of divergent cytokines by the shared signaling receptor gp130

Molecular Cell

Volumn 12, Issue 3, 2003, Pages 577-589

  Boulanger, Martin J ^a   Bankovich, Alexander J ^a   Kortemme, Tanja ^b   Baker, David ^b   Garcia, K Christopher ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; LIGAND; RECEPTOR;

ARTICLE; BINDING SITE; CHEMISTRY; COMPARATIVE STUDY; CROSS REACTION; CRYSTAL STRUCTURE; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; PLASTICITY; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; THERMODYNAMICS;

EID: 0141527338     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00365-4     Document Type: Article

References (46)

1. Atwell S., Ultsch M., De Vos A.M., Wells J.A. Structural plasticity in a remodeled protein-protein interface. Science. 278:1997;1125-1128.
2. Bazan J.F. Haemopoietic receptors and helical cytokines. Immunol. Today. 11:1990;350-354.
3. Benigni F., Fantuzzi G., Sacco S., Sironi M., Pozzi P., Dinarello C.A., Sipe J.D., Poli V., Cappelletti M., Paonessa G.et al. Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1. Blood. 87:1996;1851-1854.
4. Boulanger M.J., Chow D.C., Brevnova E.E., Garcia K. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science. 300:2003;2101-2104.
5. Bravo J., Staunton D., Heath J.K., Jones E.Y. Crystal structure of a cytokine-binding region of gp130. EMBO J. 17:1998;1665-1674.
6. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P.R.W., Jiang J.S., Kuszewski J., Nilges N., Pannu N.S., Rice L.M., Simonson T. Crystallography and NMR system (CNS). a new software system for macromolecular structure determination Acta. Cryst. D54:1998;905-921.
7. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 403:2000;434-439.
8. Chow D., He X., Snow A.L., Rose-John S., Garcia K.C. Structure of an extracellular gp130 cytokine receptor signaling complex. Science. 291:2001;2150-2155.
9. DeLano W.L., Ultsch M.H., de Vos A.M., Wells J.A. Convergent solutions to binding at a protein-protein interface. Science. 287:2000;1279-1283.
10. Deller M.C., Hudson K.R., Ikemizu S., Bravo J., Jones E.Y., Heath J.K. Crystal structure and functional dissection of the cytostatic cytokine oncostatin M. Struct. Fold. Des. 8:2000;863-874.
11. Esnouf R.M. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. 15:1997;132-134.
12. Garcia K.C., Degano M., Pease L.R., Huang M., Peterson P.A., Teyton L., Wilson I.A. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1998;1166-1172.
13. GrandPre T., Nakamura F., Vartanian T., Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 403:2000;439-444.
14. Gyotoku E., Morita E., Kameyoshi Y., Hiragun T., Yamamoto S., Hide M. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice. Arch. Dermatol. Res. 293:2001;508-514.
15. Hammacher A., Richardson R.T., Layton J.E., Smith D.K., Angus L.J., Hilton D.J., Nicola N.A., Wijdenes J., Simpson R.J. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J. Biol. Chem. 273:1998;22701-22707.
16. Heinrich P.C., Behrmann I., Muller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334:1998;297-314.
17. Hibi M., Murakami M., Saito M., Hirano T., Taga T., Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell. 63:1990;1149-1157.
18. Hilton D.J., Nicola N.A., Metcalf D. Purification of a murine leukemia inhibitory factor from Krebs ascites cells. Anal. Biochem. 173:1988;359-367.
19. Hirano T., Nakajima K., Hibi M. Signaling mechanisms through gp130. a model of the cytokine system Cytokine Growth Factor Rev. 8:1997;241-252.
20. Horsten U., Muller-Newen G., Gerhartz C., Wollmer A., Wijdenes J., Heinrich P.C., Grotzinger J. Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J. Biol. Chem. 272:1997;23748-23757.
21. Hudson K.R., Vernallis A.B., Heath J.K. Characterization of the receptor binding sites of human leukemia inhibitory factor and creation of antagonists. J. Biol. Chem. 271:1996;11971-11978.
22. Humphrey W., Dalke A., Schulten K. J. Mol. Graph. 14:1996;33.
23. Jones T.A., Zhou J.Y., Cowan S.W., Kjeldgaard M. Improved methods for building models in electron density maps and the location of error in these models. Acta Crystallogr. A47:1991;110-119.
24. Kalai M., Montero-Julian F.A., Grotzinger J., Fontaine V., Vandenbussche P., Deschuyteneer R., Wollmer A., Brailly H., Content J. Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level. proposed mechanism of interaction Blood. 89:1997;1319-1333.
25. Kortemme T., Baker D. A simple physical model for binding energy hot spots in protein-protein complexes. Proc. Natl. Acad. Sci. USA. 99:2002;14116-14121.
26. Kraulis P. Molscript. a program to produce both detailed and schematic plots of protein structures J. Appl. Crystallogr. 24:1991;946-950.
27. Kurth I., Horsten U., Pflanz S., Timmermann A., Kuster A., Dahmen H., Tacken I., Heinrich P.C., Muller-Newen G. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J. Immunol. 164:2000;273-282.
28. Laskowksi R.A., MacArthur M.W., Moss D.S., Thornton J.M. Procheck. a program to check the stereochecmial quality of protein structures J. Appl. Crystallogr. 26:1993;283-291.
29. Livnah O., Stura E.A., Johnson D.L., Middleton S.A., Mulcahy L.S., Wrighton N.C., Dower W.J., Jolliffe L.K., Wilson I.A. Functional mimicry of a protein hormone by a peptide agonist. the EPO receptor complex at 2.8 A Science. 273:1996;464-471.
30. Mattos C., Ringe D. Locating and characterizing binding sites on proteins. Nat. Biotechnol. 14:1996;595-599.
31. Merritt E.A., Murphy E.P.M. Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 50:1994;869-873.
32. Moreau J.F., Donaldson D.D., Bennett F., Witek-Giannotti J., Clark S.C., Wong G.G. Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature. 336:1988;690-692.
33. Murphy M., Reid K., Hilton D.J., Bartlett P.F. Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc. Natl. Acad. Sci. USA. 88:1991;3498-3501.
34. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
35. Patterson B.K., McCallister S., Schutz M., Siegel J.N., Shults K., Flener Z., Landay A. Persistence of intracellular HIV-1 mRNA correlates with HIV-1-specific immune responses in infected subjects on stable HAART. AIDS. 15:2001;1635-1641.
36. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature. 403:2000;383-384.
37. Robinson R.C., Grey L.M., Staunton D., Vankelecom H., Vernallis A.B., Moreau J.F., Stuart D.I., Heath J.K., Jones E.Y. The crystal structure and biological function of leukemia inhibitory factor. implications for receptor binding Cell. 77:1994;1101-1116.
38. Sanner M.F., Spehner J.-C., Olson A.J. Biopolymers. 38:1996;305.
39. Schumacher M.A., Miller M.C., Grkovic S., Brown M.H., Skurray R.A., Brennan R.G. Structural mechanisms of QacR induction and multidrug recognition. Science. 294:2001;2158-2163.
40. Simpson R.J., Hammacher A., Smith D.K., Matthews J.M., Ward L.D. Interleukin-6. structure-function relationships Protein Sci. 6:1997;929-955.
41. Sundberg E.J., Mariuzza R.A. Luxury accommodations. the expanding role of structural plasticity in protein-protein interactions Struct. Fold. Des. 8:2000;R137-R142.
42. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:1997;797-819.
43. Timmermann A., Kuster A., Kurth I., Heinrich P.C., Muller-Newen G. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Eur. J. Biochem. 269:2002;2716-2726.
44. Vagin V., Teplyakov A. J. Appl. Cryst. 30:1997;1022.
45. Voisin M.B., Bitard J., Daburon S., Moreau J.F., Taupin J.L. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation. J. Biol. Chem. 277:2002;13682-13692.
46. Yamamori T., Fukada K., Aebersold R., Korsching S., Fann M.J., Patterson P.H. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science. 246:1989;1412-1416.